Search This Blog

Friday, October 21, 2022

Pfizer expected to hike U.S. COVID vaccine price to $110-$130 per dose

 Yahoo Finance's Anjalee Khemlani discusses Pfizer raising prices for COVID vaccines

Video Transcript

AKIKO FUJITA: Well, the cost of Pfizer's COVID vaccine is going to quadruple after the current purchase program expires in the US. Earlier this week, Julie Hyman spoke to the company's CEO Albert Bourla about pricing here's what he had to say

ALBERT BOURLA: The vaccines will be priced based on their cost effectiveness. And the cost effectiveness is multiple of what it is right now the price when we give to the governments in the pandemic.

AKIKO FUJITA: Yahoo Finance senior health reporter Anjalee Khemlani here to break it all down for us. How big of a surprise is this? This is sort of an expected thing.

ANJALEE KHEMLANI: This is an expected thing. The number is the part that's new. So $110 to $130, that's what the news that we just found out. And that's from an analyst call yesterday that Pfizer had.

And I want to dig down into the details because it is important to understand what's baked in to this pricing. It's things like the cost of a single dose vaccine packaging, the fact that they're now going to be distributing through multiple sources rather than just through the government and through that single channel of the distributor. And the mailing, and delivery service, and transportation, that all goes away once the government contract ends.

And so what they're looking at is early Q1-- or sorry, late Q1, so earlier next year is when they're looking to really transition more into this commercial environment. That also includes, by the way, the discussion about the cost and who's paying for it. It's going to be borne by insurers. And so most Americans won't really be impacted by this price shift.

But it's important to point out that Pfizer did note that the uninsured are going to be taken care of. In a quote, they said, "Eligible US residents without insurance will be able to access the COVID-19 vaccine for free." So that stays in place as well through their current assistance programs for patients.

So all of that put together really, you know, paints a picture of an expected commercial market. The price itself is not outrageous. We do know that there are vaccines within that price range over $100. So like you said, not really unexpected.

https://finance.yahoo.com/video/pfizer-expected-hike-u-covid-160716553.html

Cerevel started at Buy by B of A

 Target $39

https://finviz.com/quote.ashx?t=CERE&ty=c&ta=1&p=d

HCA Q3

 

Revenues in the third quarter of 2022 totaled $14.971 billion, compared to $15.276 billion in the third quarter of 2021. Net income attributable to HCA Healthcare, Inc. totaled $1.134 billion, or $3.91 per diluted share, compared to $2.269 billion, or $7.00 per diluted share, in the third quarter of 2021. Results for the third quarter of 2022 include losses on sales of facilities of $3 million, or $0.02 per diluted share. Results for the third quarter of 2021 include gains on sales of facilities of $1.047 billion, or $2.43 per diluted share, related to the sale of four hospitals in Georgia and other health care entity investments. In September 2022, the state of Florida received approval from the Centers for Medicare and Medicaid Services for its directed payment program for the program year that began October 1, 2021 and ended September 30, 2022. Revenues for the third quarter of 2022 include approximately $266 million for the full program year. Other operating expenses include approximately $125 million from provider tax assessments related to the same period.

For the third quarter of 2022, Adjusted EBITDA totaled $2.902 billion, compared to $3.224 billion in the third quarter of 2021. Adjusted EBITDA is a non-GAAP financial measure. A table providing supplemental information on Adjusted EBITDA and reconciling net income attributable to HCA Healthcare, Inc. to Adjusted EBITDA is included in this release.

Results for the third quarter 2022 include Hurricane Ian’s impact, primarily on our Florida facilities, causing additional expenses and lost revenues estimated at $35 million. This amount is prior to any potential insurance recoveries.

Same facility admissions declined 1.5 percent while same facility equivalent admissions increased 2.3 percent in the third quarter of 2022, compared to the prior year period. Same facility emergency room visits declined 1.3 percent in the third quarter of 2022, compared to the prior year period. Same facility inpatient surgeries increased 5.6 percent, and same facility outpatient surgeries increased 2.0 percent in the third quarter of 2022, compared to the same period of 2021. Same facility revenue per equivalent admission declined 3.5 percent in the third quarter of 2022, compared to the third quarter of 2021. Year over year comparisons were impacted by significantly higher COVID-19 volumes in the prior year, when COVID-19 represented 12.7 percent of same-facility admissions versus 5.2 percent in the current year quarter.

Earnings Conference Call

HCA Healthcare will host a conference call for investors at 8:00 a.m. Central Daylight Time today. All interested investors are invited to access a live audio broadcast of the call via webcast. The broadcast also will be available on a replay basis beginning this afternoon. The webcast can be accessed at: https://investor.hcahealthcare.com/events-and-presentations.

https://finance.yahoo.com/news/hca-healthcare-reports-third-quarter-103000747.html

Altamira to Divest Inner Ear Development Assets

 

  • Definitive agreement to sell 90% stake in Company’s Zilentin subsidiary with option to acquire all of Altamira’s remaining inner ear development assets in Q4 2022

  • Company to receive immediate cash payment of $2 million, $25 million second upfront payment upon option exercise, and potential milestone payments of up to $55 million and future royalties

  • Buyer is a European family office seeking to continue and expand Altamira’s projects in hearing loss, tinnitus, and vertigo

  • Transaction represents important first step in Altamira’s strategy to focus solely on RNA delivery

  • Company actively working towards divestiture of BentrioTM before year-end

Teva resumed at Buy by Jefferies

 Target $10

https://finviz.com/quote.ashx?t=TEVA&p=d

Adams says mental illness driving subway safety woes — not guns

 Mayor Eric Adams U-turned Thursday and said that mental health issues — not illegal guns — are driving a months-long spate of violence underground on the subways.

Hizzoner acknowledged the link just days after he dismissed the premise Monday and blamed the surge in homicides and attacks underground on firearms flooding the streets of the Big Apple.

“When you do an analysis of the subway crimes we are seeing, you are seeing it is driven by people with mental health issues,” Adams told reporters during a press conference about an unrelated event in Brooklyn.

“If you got a ninja outfit on and you are running around with a sword, then something is wrong,” he said, apparently referring to an attack with a sword scabbard in the subway Thursday.

He then added: “Michelle Go’s murder,” referring to the fatal subway shoving attack in January that made headlines around the world, “you are seeing this mental health issue that we are facing.”

This is a sharp u-turn from his previous claims that illegal guns are causing the increase.
Mayor Eric Adams said that mental health issues are driving the subway crime spike.
Michael Brochstein/Sipa USA

Go’s attacker, Martial Simon, was deemed unfit to stand trial for reasons of mental illness and confined to an institution.

City Hall, Adams said, is looking to step up its response and would announce new efforts in the “couple of days” to combat untreated mental illness and homelessness in the subways.

The mayor’s remarks stood in sharp contrast to his statements earlier in the week, when he downplayed connecting untreated mental health issues to the spasms of violence on the subways, which exploded in the aftermath of the coronavirus pandemic.

There has been a sharp increase in subway crimes in recent months.
Last week, Adams downplayed untreated mental health issues as the cause of increase.
Robert Miller

There have been nine homicides underground so far this year, up from six reported in 2021 and two in 2020. All of those figures are well in excess of pre-pandemic levels, when the system system usually averaged an entire year or more between murders.

“Success is no one being in any way impacted by anyone that’s dealing with emotional issues or violence because you sort of brought them both together,” Adams told a reporter.

“I think we have eight homicides this year, two more than last year,” he continued. “You can’t tie all of them to people with emotional issues.”

Go's shover was deemed too mentally ill to stand trial.
Michelle Go was killed by a subway shover in January.
Stephen Yang

When pressed why the homicide figures had surged, Adams then blamed guns — even though they’ve only been linked to three of the 17 homicides since the COVID outbreak.

“Those guns that are on our streets, they’re also in our subway system, they’re also in our schools,” he said. “They’re everywhere we are as innocent New Yorkers.”

Adams couched his about-face on Thursday by claiming that his remarks from Monday had been “misinterpreted” by reporters and that he had been talking about the fatal subway shooting of teenager on the Rockaways.

City Hall Press Secretary Fabien Levy disputed that Adams had reversed himself on the major causes of subway crime.

“As the mayor always says, there are many rivers feeding the sea of violence in our city, and we need to dam every one,” he said in a statement. “One of those rivers is gun violence and another is the mental health crisis.”

https://nypost.com/2022/10/20/mental-illness-driving-subway-crime-spike-not-guns-eric-adams/

Thursday, October 20, 2022

Manipulating stress response in cells could help slow down aging

 Scientists at Nanyang Technological University, Singapore (NTU Singapore) have found that a stress response in cells, when 'switched on' at a post-reproductive age, could be the key to slow down ageing and promote longevity.

In lab experiments on a type of roundworm that shares similarities with humans, the NTU Singapore team found that switching on this stress response in aged worms by feeding them a high-glucose diet extended their lifespan as compared to worms fed a normal diet.

This is the first time a link between this stress response and ageing has been uncovered, said the NTU team of their findings published on 19 October in Nature Communications.

While further studies are needed to gain a deeper understanding of this link, the scientists said their findings open the door to the development of therapies that could delay the onset or even tackle age-related disorders such as cancer, dementia, and stroke.

Cell biologist and study lead Associate Professor Guillaume Thibault from the NTU School of Biological Sciences said: "Ageing is a critical risk factor for a variety of human pathologies, from metabolic diseases such as diabetes to cancer and neurodegenerative diseases. From a public health perspective, determining the cellular pathways that underpin the ageing process could take us one step closer to developing novel therapeutic strategies to treat age-related disorders.

"While our study found that a high-glucose diet could be useful to slow down ageing and promote longevity in aged worms, we are not recommending that the aged population should now turn to a high-sugar diet. What this study does show is that triggering certain stress responses in cells may translate to longevity, and that activating this stress response with a drug might be critical to decelerate cellular ageing."

Aside from showing that the effect of manipulating this stress response in aged worms, the NTU scientists also showed that the same response, when 'switched off' in young worms fed a high-glucose diet, helped them to live longer than worms on a normal diet.

Commenting as an independent expert, Professor Rong Li, Director of the Mechanobiology Institute at the National University of Singapore said: "Metabolic diseases have serious consequences in the elderly if left untreated. This work is impactful because the scientists identified a cellular pathway, called the unfolded protein response, which affects lifespan in animals fed a high glucose diet. They found that inhibiting this pathway dramatically extended the lifespan of these animals. They therefore propose that targeting this pathway may extend lifespan in humans with metabolic disorder."

This study is aligned with the research pillar of the University's NTU2025 five-year strategic plan, which focuses on health and society as one area with potential for significant intellectual and societal impact.

How the cell's stress response is activated

Cells produce a stress response when stressors (such as an excess of glucose) cause a build-up of problematic 'unfolded' proteins in the cell. The stress response, called the unfolded protein response, works to clear up these problematic proteins to restore balance in the cell.

Ageing could also lead to an accumulation of unfolded proteins due a natural decline in the ability of the cell's machinery to produce healthy proteins, triggering the same stress response.

The molecular machinery in the cell tackles this build-up through its 'stress sensors', which initiate a series of molecular mechanisms to rescue the cell from this stress. If the overload of unfolded proteins is not resolved, the prolonged unfolded protein response induces cell death instead.

Unfolded protein response in aged worms led to healthier ageing

To investigate how the unfolded protein response affects longevity in animals, the scientists induced this response in adult roundworms (Caenorhabditis elegans) using glucose. While C. elegans is significantly anatomically simpler than a human, it relies on many of the same genes that humans do to control the division of cells and to programme faulty cells to die.

The scientists fed some of the worms a high-glucose diet at two different life stages: young i.e.at the start of their adulthood (Day 1), and at a post-reproductive age (Day 5), when the worms are aged and no longer fertile. A control group of worms were fed a normal diet throughout.

The scientists found that the aged worms given a high-glucose diet lived for 24 days -- almost twice the lifespan of the young worms given the same diet (13 days). Worms on a normal diet lived for 20 days.

Aside from living longer, the aged worms on a high-glucose diet were more agile and had more energy storage cells as compared to worms given a normal diet, suggesting healthier ageing.

Prolonged stress response in young worms led to cell death

A day after feeding the worms a high-glucose diet, the NTU scientists monitored the activity of the three stress sensors that are each responsible for a cellular pathway in the unfolded protein response.

They found that that one of the stress sensors, IRE1, was significantly more active in young worms compared to aged worms.

When the scientists removed the gene coding for IRE1 in worms to 'switch off' the cellular pathway the stress sensor initiates, they found that young worms fed a high-glucose diet from Day 1 lived for 25 days -- twice as long as when the IRE1 gene was intact.

This suggests that the increased activity of stress sensor IRE1 seen in young worms fed a high-glucose diet from Day 1 -- what the scientists say is a prolonged unfolded protein response -- was responsible for shortening their lifespan.

Assoc Prof Thibault said: "We believe that the high-glucose diet fed to the aged worms stimulated their otherwise sluggish unfolded protein response and switched on certain cellular pathways, tackling not just the stress caused by excess glucose but also other ageing-related stress, restoring cellular stability.

"In contrast, young worms subjected to a high-glucose diet provoked unresolved stress in the cells due to an overactivated IRE1. This prolonged activation led the cells to initiate cell death instead."

The findings suggest that a drug that reduces the activity of IRE1 while increasing the activity of the other two stress sensors could potentially be developed to decelerate cellular ageing and consequently extend lifespans, he added.

More studies and findings will need to be conducted in the roundwormsto further dissect the complex mechanism behind the lifespan extension induced by a high-glucose diet, as well as how this mechanism interacts with other processes in cells.

Other authors of the study are research fellow Dr Cenk Celik and research assistant Aishah Tul-Firdaus Abdul Khalid from NTU; former NTU researchers Caroline Beaudoin-Chabot, Wang Lei, Subhash Thalappilly, Xu Shiyi; and NTU graduates Koh Jhee Hong, Venus Lim Wen Xuan, and Low Ann Don.

Lifespan of C. elegans (stress response is switched on)

Worms on a high-glucose diet from Day 1: 13 days

Worms on a high-glucose diet from Day 5: 24 days

Worms on a normal diet: 20 days

Lifespan of C. elegans with IRE1 gene removed (stress response is switched off)

Worms on a high-glucose diet from Day 1: 25 days

Worms on a high-glucose diet from Day 5: 19 days

Worms on a normal diet: 16 days

This work was supported by the Singapore Ministry of Education Academic Research Fund Tier 2 (2018-T2-1-002) and Tier 1 (2019-T1-002-011); and the Ministry of Health, Singapore, National Medical Research Council Open Fund Individual Research Grant (MOH-000566).


Story Source:

Materials provided by Nanyang Technological UniversityNote: Content may be edited for style and length.


Journal Reference:

  1. Caroline Beaudoin-Chabot, Lei Wang, Cenk Celik, Aishah Tul-Firdaus Abdul Khalid, Subhash Thalappilly, Shiyi Xu, Jhee Hong Koh, Venus Wen Xuan Lim, Ann Don Low, Guillaume Thibault. The unfolded protein response reverses the effects of glucose on lifespan in chemically-sterilized C. elegansNature Communications, 2022; 13 (1) DOI: 10.1038/s41467-022-33630-0